Evidence map›Paper›PMID 35730612›Full record

ArticleJournal of the American Heart Association2022

To Be or Not to Be Treated: That Is the Question in Managing a Fetus With Cardiac Injury Exposed to Anti-SSA/Ro.

Jill Buyon, Amit Saxena, Deborah Friedman, Peter Izmirly

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. To Be or Not to Be: Surviving Immune-Mediated Fetal Heart Disease.Journal of the American Heart Association · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Jill BuyonDivision of Rheumatology Department of Medicine New York University Grossman School of Medicine New York NY.ORCID 0000-0002-3852-7129
Amit SaxenaDivision of Rheumatology Department of Medicine New York University Grossman School of Medicine New York NY.
Deborah FriedmanDepartment of Pediatrics New York Medical College Valhalla NY.
Peter IzmirlyDivision of Rheumatology Department of Medicine New York University Grossman School of Medicine New York NY.ORCID 0000-0001-5445-2182

Funding

Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)R01HD079951 · NICHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P · 2015 to 2019
$1.4M
RESEARCH REGISTRY FOR NEONATAL LUPUSN01AR42271 · NIAMS · NEW YORK UNIVERSITY · PI BUYON, JILL P · 2007 to 2010
$1.1M
Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH)R03HD069986 · NICHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P · 2012 to 2014
$249k
RESEARCH REGISTRY FOR NEONATAL LUPUS-264942220N01AR042220 · NIAMS · HOSPITAL FOR JOINT DISEASES ORTHO INST · 1994 to 2003
$148k
NIAMS NIH HHS N01 AR042220NIAMS NIH HHS N01AR42271NICHD NIH HHS R01 HD079951NICHD NIH HHS R03 HD069986
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, AntinuclearLupus Erythematosus, SystemicAutoantibodiesFetusHumansAntibodies, AntinuclearAutoantibodies

Identifiers

PMID35730612
PMCPMC9333387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.